A Database Survey of Comparison The Risk of Haemorrhage between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants with Depressio
Not Applicable
- Conditions
- Depression
- Registration Number
- JPRN-jRCT2031230194
- Lead Sponsor
- Contact for Clinical Trial Information
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 115000
Inclusion Criteria
1.Has diagnosis of depression and prescription of Vortioxetine tablet or SSRI within the enrollment period (Index Date: first prescription date within the enrollment period).
2.Participants can be observed for the past 6 months (180 days) (Look back period) from the day before the Index Date.
3.Had not prescription of Vortioxetine tablet or SSRI in the Look back period.
Exclusion Criteria
1.Has diagnosis of intracranial hemorrhage during the look back period.
2.Has been taken Vortioxetine tablet in combination with SSRI on the index date.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method